Mitochondrial translation initiation factor 3 polymorphism and Parkinson's disease

Neuroscience Letters

Volumn 486, Issue 3, 2010, Pages 228-230

  Behrouz, Bahareh ^a   Vilariño Güell, Carles ^a   Heckman, Michael G ^b   Soto Ortolaza, Alexandra I ^a   Aasly, Jan O ^c   Sando, Sigrid ^c   Lynch, Timothy ^d,e   Craig, David ^f   Uitti, Ryan J ^b   Wszolek, Zbigniew K ^b   Ross, Owen A ^a   Farrer, Matthew J ^a  

^a MAYO GRADUATE SCHOOL   (United States)

^b MAYO CLINIC   (United States)

^c NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^d MATER MISERICORDIAE UNIVERSITY HOSPITAL   (Ireland)

^e UNIVERSITY COLLEGE DUBLIN   (Ireland)

^f QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

Author keywords

Association studies; Genetics; MTIF3; Parkinson's disease

Indexed keywords

ADENOSINE TRIPHOSPHATE; DNA; INITIATION FACTOR 3; MITOCHONDRIAL TRANSLATION INITIATION FACTOR 3; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DEGENERATIVE DISEASE; DISEASE PREDISPOSITION; FEMALE; GENETIC ASSOCIATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MITOCHONDRION; NEUROLOGIC DISEASE; PARKINSON DISEASE; PRIORITY JOURNAL; RISK; SINGLE NUCLEOTIDE POLYMORPHISM; TRANSLATION INITIATION;

ADENOSINE TRIPHOSPHATE; ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; EUKARYOTIC INITIATION FACTORS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; IRELAND; MALE; MIDDLE AGED; MITOCHONDRIAL DISEASES; MITOCHONDRIAL PROTEINS; NORWAY; PARKINSON DISEASE; POLYMORPHISM, SINGLE NUCLEOTIDE; UNITED STATES;

EID: 78049388018     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2010.09.059     Document Type: Article

References (19)

1. Abahuni N., Gispert S., Bauer P., Riess O., Kruger R., Becker T., Auburger G. Mitochondrial translation initiation factor 3 gene polymorphism associated with Parkinson's disease. Neuroscience Letters 2007, 414:126-129.
2. Bonifati V., Rizzu P., van Baren M.J., Schaap O., Breedveld G.J., Krieger E., Dekker M.C., Squitieri F., Ibanez P., Joosse M., van Dongen J.W., Vanacore N., van Swieten J.C., Brice A., Meco G., van Duijn C.M., Oostra B.A., Heutink P. Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism. Science (New York, NY) 2003, 299:256-259.
3. Christian B.E., Spremulli L.L. Evidence for an active role of IF3mt in the initiation of translation in mammalian mitochondria. Biochemistry 2009, 48:3269-3278.
4. Clark I.E., Dodson M.W., Jiang C., Cao J.H., Huh J.R., Seol J.H., Yoo S.J., Hay B.A., Guo M. Drosophila pink1 is required for mitochondrial function and interacts genetically with parkin. Nature 2006, 441:1162-1166.
5. Dodson M.W., Guo M. Pink1 Parkin DJ-1 and mitochondrial dysfunction in Parkinson's disease. Current Opinion in Neurobiology 2007, 17:331-337.
6. Fahn S. Description of Parkinson's disease as a clinical syndrome. Annals of the New York Academy of Sciences 2003, 991:1-14.
7. Farrer M.J. Genetics of Parkinson disease: paradigm shifts and future prospects. Nature Reviews 2006, 7:306-318.
8. Gelb D.J., Oliver E., Gilman S. Diagnostic criteria for Parkinson disease. Archives of Neurology 1999, 56:33-39.
9. Greenamyre J.T., Hastings T.G. Biomedicine. Parkinson's-divergent causes, convergent mechanisms. Science (New York, NY) 2004, 304:1120-1122.
10. Kimchi-Sarfaty C., Oh J.M., Kim I.W., Sauna Z.E., Calcagno A.M., Ambudkar S.V., Gottesman M.M. A "silent" polymorphism in the MDR1 gene changes substrate specificity. Science (New York, NY) 2007, 315:525-528.
11. Kitada T., Asakawa S., Hattori N., Matsumine H., Yamamura Y., Minoshima S., Yokochi M., Mizuno Y., Shimizu N. Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature 1998, 392:605-608.
12. Koc E.C., Spremulli L.L. Identification of mammalian mitochondrial translational initiation factor 3 and examination of its role in initiation complex formation with natural mRNAs. The Journal of Biological Chemistry 2002, 277:35541-35549.
13. Komar A.A. Silent SNPs: impact on gene function and phenotype. Pharmacogenomics 2007, 8:1075-1080.
14. Langston J.W., Langston E.B., Irwin I. MPTP-induced parkinsonism in human and non-human primates-clinical and experimental aspects. Acta Neurologica Scandinavica 1984, 100:49-54.
15. Park J., Lee S.B., Lee S., Kim Y., Song S., Kim S., Bae E., Kim J., Shong M., Kim J.M., Chung J. Mitochondrial dysfunction in Drosophila PINK1 mutants is complemented by parkin. Nature 2006, 441:1157-1161.
16. Schapira A.H., Cooper J.M., Dexter D., Clark J.B., Jenner P., Marsden C.D. Mitochondrial complex I deficiency in Parkinson's disease. Journal of Neurochemistry 1990, 54:823-827.
17. Sharma M.R., Koc E.C., Datta P.P., Booth T.M., Spremulli L.L., Agrawal R.K. Structure of the mammalian mitochondrial ribosome reveals an expanded functional role for its component proteins. Cell 2003, 115:97-108.
18. Valente E.M., Abou-Sleiman P.M., Caputo V., Muqit M.M., Harvey K., Gispert S., Ali Z., Del Turco D., Bentivoglio A.R., Healy D.G., Albanese A., Nussbaum R., Gonzalez-Maldonado R., Deller T., Salvi S., Cortelli P., Gilks W.P., Latchman D.S., Harvey R.J., Dallapiccola B., Auburger G., Wood N.W. Hereditary early-onset Parkinson's disease caused by mutations in PINK1. Science (New York, NY) 2004, 304:1158-1160.
19. Van Laar V.S., Berman S.B. Mitochondrial dynamics in Parkinson's disease. Experimental Neurology 2009, 218:247-256.